Nephros, Inc. (NEPH)

USD 1.48

(-3.9%)

Revenue Summary of Nephros, Inc.

  • Nephros, Inc.'s latest annual revenue in 2023 was 14.23 Million USD , up 42.74% from previous year.
  • Nephros, Inc.'s latest quarterly revenue in 2024 Q1 was 3.52 Million USD , up 8.24% from previous quarter.
  • Nephros, Inc. reported a annual revenue of 9.97 Million USD in annual revenue 2022, down -4.12% from previous year.
  • Nephros, Inc. reported a annual revenue of 10.4 Million USD in annual revenue 2021, up 21.53% from previous year.
  • Nephros, Inc. reported a quarterly revenue of 3.25 Million USD for 2024 Q2, down -7.67% from previous quarter.
  • Nephros, Inc. reported a quarterly revenue of 3.69 Million USD for 2023 Q1, up 44.53% from previous quarter.

Annual Revenue Chart of Nephros, Inc. (2023 - 2001)

Historical Annual Revenue of Nephros, Inc. (2023 - 2001)

Year Revenue Revenue Growth
2023 14.23 Million USD 42.74%
2022 9.97 Million USD -4.12%
2021 10.4 Million USD 21.53%
2020 8.56 Million USD -17.16%
2019 10.33 Million USD 81.71%
2018 5.68 Million USD 49.3%
2017 3.8 Million USD 64.18%
2016 2.32 Million USD 19.34%
2015 1.94 Million USD 11.21%
2014 1.74 Million USD 0.46%
2013 1.74 Million USD -3.71%
2012 1.8 Million USD -18.38%
2011 2.21 Million USD -24.64%
2010 2.93 Million USD 10.41%
2009 2.66 Million USD 80.65%
2008 1.47 Million USD 23.16%
2007 1.19 Million USD 50.73%
2006 793.48 Thousand USD -67.27%
2005 2.42 Million USD 1651.72%
2004 138.4 Thousand USD 0.0%
2003 - USD 0.0%
2002 - USD -100.0%
2001 300 Thousand USD 0.0%

Peer Revenue Comparison of Nephros, Inc.

Name Revenue Revenue Difference
Akoya Biosciences, Inc. 96.63 Million USD 85.266%
AngioDynamics, Inc. 303.91 Million USD 95.315%
AtriCure, Inc. 399.24 Million USD 96.434%
Avinger, Inc. 7.65 Million USD -86.069%
Azenta, Inc. 665.07 Million USD 97.859%
BioLife Solutions, Inc. 143.27 Million USD 90.062%
The Cooper Companies, Inc. 3.59 Billion USD 99.604%
Daxor Corporation 1.28 Million USD -1011.896%
Ekso Bionics Holdings, Inc. 18.27 Million USD 22.107%
Femasys Inc. 1.07 Million USD -1228.209%
GlucoTrack, Inc. - USD -Infinity%
Harvard Bioscience, Inc. 112.25 Million USD 87.316%
Hologic, Inc. 4.03 Billion USD 99.647%
ICU Medical, Inc. 2.25 Billion USD 99.37%
Intuitive Surgical, Inc. 7.12 Billion USD 99.8%
KORU Medical Systems, Inc. 28.51 Million USD 50.073%
LeMaitre Vascular, Inc. 193.48 Million USD 92.641%
Innovative Eyewear, Inc. 1.15 Million USD -1135.424%
Innovative Eyewear, Inc. 1.15 Million USD -1135.424%
Masimo Corporation 2.04 Billion USD 99.305%
Microbot Medical Inc. - USD -Infinity%
Meihua International Medical Technologies Co., Ltd. 97.09 Million USD 85.337%
Merit Medical Systems, Inc. 1.25 Billion USD 98.868%
NovoCure Limited 509.33 Million USD 97.205%
NEXGEL, Inc. 4.08 Million USD -248.202%
NEXGEL, Inc. 4.08 Million USD -248.202%
Singular Genomics Systems, Inc. 2.91 Million USD -389.11%
OraSure Technologies, Inc. 405.47 Million USD 96.489%
Pro-Dex, Inc. 53.84 Million USD 73.557%
Pulse Biosciences, Inc. - USD -Infinity%
Predictive Oncology Inc. 1.78 Million USD -699.846%
Precision Optics Corporation, Inc. 19.1 Million USD 25.472%
QuidelOrtho Corporation 2.99 Billion USD 99.525%
Repligen Corporation 638.76 Million USD 97.771%
Sanara MedTech Inc. 64.98 Million USD 78.092%
STAAR Surgical Company 322.41 Million USD 95.584%
Sharps Technology, Inc. - USD -Infinity%
Utah Medical Products, Inc. 50.22 Million USD 71.651%
DENTSPLY SIRONA Inc. 3.96 Billion USD 99.641%
Jin Medical International Ltd. 19.82 Million USD 28.169%